For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Samyang Biopharmaceuticals Corporation

USPTO Granted Patents = 36

CIPO Patents = 11

EPO Patents = 40

Trademarks = 6

Forward Citations = 80

Loading Chart...

Loading Chart...

86 inventors (with patents filed for the assignee):

Min-Hyo Seo (10 out of 26 patents)

Min Hyo Seo (9 out of 18 patents)

Sa-Won Lee (6 out of 7 patents)

4. Bong Oh Kim (6 out of 9 patents)

5. Sa Won Lee (4 out of 8 patents)

6. Ji-Yeon Son (3 out of 8 patents)

7. Joong-Woong Cho (3 out of 3 patents)

8. Gyeong-Hae Kim (3 out of 3 patents)

9. Muhn-Ho La (3 out of 3 patents)

10. Guw-Dong Yeo (3 out of 4 patents)

11. Sung-Won Choi (2 out of 2 patents)

12. Sun-Woo Kim (2 out of 3 patents)

13. Yil Woong Yi (2 out of 3 patents)

14. Jun-Bae Kim (2 out of 16 patents)

15. Hye-Jeong Yoon (2 out of 3 patents)

36 patents: Sort by Forward Citations

1. 10793516 - Method for selectively synthesizing cationic lipids (2020-10-06),

2. 10765753 - Polymer nanoparticle freeze-dried product, and preparation method therefor (2020-09-08),

3. 10739319 - Method for analyzing related substances of a pharmaceutical composition containing a polymeric carrier (2020-08-11),

4. 10456362 - Stabilized pharmaceutical composition and method for preparing same (2019-10-29),

5. 10300063 - Pharmaceutical composition not containing antioxidant and preparation method therefor (2019-05-28),

6. 10292932 - Polymeric micelle particle comprising anionic drugs and method of preparing the same (2019-05-21),

7. 10022477 - Composition for anti-adhesion, surgical mesh composite with anti-adhesion property comprising the same and method for producing thereof (2018-07-17),

8. 9931411 - Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same (2018-04-03),

9. 9883935 - Process for preparing hernia mesh from monofilament (2018-02-06),

10. 9877959 - Pharmaceutical composition containing palonosetron (2018-01-30),

11. 9801818 - Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug (2017-10-31),

12. 9795562 - Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug (2017-10-24),

13. 9603931 - Macromolecule for delivering protein, polypeptide or peptide drugs and a production method for the same, and a slow release composition for protein, polypeptide or peptide drugs and a production method for the same (2017-03-28),

14. 9591849 - Matrix type antimicrobial vehicle and manufacturing method thereof (2017-03-14),

15. 9526789 - Highly robust fast-disintegrating tablet and process for manufacturing the same (2016-12-27),

Samyang Biopharmaceuticals Corporation is a leading global pharmaceutical company dedicated to the development and production of innovative and affordable medicines. With a history of more than 60 years, we strive to enhance the quality of life for patients worldwide. Our extensive portfolio includes a wide range of therapeutic areas such as oncology, respiratory, cardiovascular, and central nervous system disorders. Through cutting-edge research and manufacturing facilities, we deliver high-quality pharmaceutical products and contribute to the advancement of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

36 Patents

#123 in Seoul

#387 in South Korea

#18,179 in the World

Seoul, South Korea

Samyang Biopharmaceuticals Corporation

Forward Citations = 80

86 inventors:

Min-Hyo Seo (10 out of 26 patents)

Min Hyo Seo (9 out of 18 patents)

Sa-Won Lee (6 out of 7 patents)

4. Bong Oh Kim (6 out of 9 patents)

5. Sa Won Lee (4 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…